Natera, Inc. splits its revenue into 5 lines in its filings. The largest line in fiscal 2025, which ended Dec 31, 2025 was Product at $2.3 billion, 100% of the total.
USD in millions. The percent under a figure is the change from the year before.
| Line |
FY 2026
Sep 30, 2026
|
FY 2025
Dec 31, 2025
|
FY 2024
Dec 31, 2024
|
FY 2023
Dec 31, 2023
|
FY 2022
Dec 31, 2022
|
FY 2021
Dec 31, 2021
|
FY 2020
Dec 31, 2020
|
FY 2019
Dec 31, 2019
|
FY 2018
Dec 31, 2018
|
FY 2017
Dec 31, 2017
|
FY 2016
Dec 31, 2016
|
|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue |
2,909
|
2,306
|
1,697
|
1,083
|
820
|
625
|
391
|
302
|
258
|
211
|
217
|
| Product |
2,893
+37.3%
share 99.5%
|
2,296
+36.2%
share 99.6%
|
1,685
+57.7%
share 99.3%
|
1,069
+34.0%
share 98.7%
|
797
+37.4%
share 97.2%
|
580
+58.0%
share 92.7%
|
367
+36.1%
share 93.9%
|
270
+12.3%
share 89.3%
|
240
+18.0%
share 93.3%
|
204
share 96.6%
|
—
|
| Other Licensing And Other |
—
|
—
|
—
|
—
|
—
|
—
|
—
|
11
+65.1%
share 3.6%
|
7
+310.7%
share 2.6%
|
2
share 0.8%
|
—
|
| Licensing And Other |
16
+75.0%
share 0.5%
|
10
-13.0%
share 0.4%
|
12
-15.7%
share 0.7%
|
14
-38.7%
share 1.3%
|
23
-49.5%
share 2.8%
|
45
+90.8%
share 7.3%
|
24
share 6.1%
|
—
|
—
|
—
|
—
|
| Upfront License And Constellation And Paternity Services |
—
|
—
|
—
|
—
|
—
|
—
|
—
|
5
-50.8%
share 1.7%
|
10
+144.6%
share 4.0%
|
4
share 2.0%
|
—
|
| License And Development Services |
—
|
—
|
—
|
—
|
—
|
—
|
—
|
—
|
0
share 0.1%
|
—
|
—
|
How these figures are calculated
Annual columns are full-year amounts from the annual report (Form 10-K, 20-F, or 40-F). If a company restates a year, the latest filed number is shown. USD in millions. Each group is a separate split of total revenue, so the groups are not added together. Share of revenue is that line divided by total revenue. The first column adds the latest year-to-date segment amount to the last fiscal year and subtracts the year-ago year-to-date amount. More on our methodology.
Company profile
- Industry
- Services-Medical Laboratories (SIC 8071)
- Listed as
- NTRA (Nasdaq)
- Fiscal year ends
- December 31
- Incorporated in
- DE
- Headquarters
- Austin, TX
- SEC filer status
- Large accelerated filer
- SEC CIK
- 1604821
- Former names
- Natera, Inc. (until Nov 6, 2026)
Other Services-Medical Laboratories companies
- Labcorp Holdings Inc. LH
- Quest Diagnostics Inc DGX
- Guardant Health, Inc. GH
- Caris Life Sciences, Inc. CAI
- GRAIL, Inc. GRAL
- RadNet, Inc. RDNT
- BillionToOne, Inc. BLLN
- CareDx, Inc. CDNA
Source: SEC EDGAR filings. This is company-reported data, not investment advice.